http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100457791-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4746 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate | 2001-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100457791-B1 |
titleOfInvention | Alphavirus-based expression vectors expressing tumor suppressor proteins, the preparation and the use thereof |
abstract | The present invention relates to alphavirus-based expression vectors for expressing foreign cancer suppressor proteins or angiogenesis inhibitor proteins, methods for their preparation and their use in the treatment of cancer. Alphaviruses are preferably Semliki Forest Virus. The alpha viral expression vector of the present invention has excellent use as a cancer therapeutic agent because it can simultaneously express and produce various cancer suppressor proteins, especially proteins such as p53, PTEN and angiostatin. |
priorityDate | 2001-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 326.